{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:42:20Z","timestamp":1773153740144,"version":"3.50.1"},"reference-count":47,"publisher":"Portland Press Ltd.","issue":"4","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":3538,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,2,1]]},"abstract":"<jats:p>Alterations within the RAS (renin\u2013angiotensin system) are pivotal for the development of renal disease. ACE2 (angiotensin-converting enzyme 2) is expressed in the kidney and converts the vasoconstrictor AngII (angiotensin II) into Ang-(1\u20137), a peptide with vasodilatory and anti-fibrotic actions. Although the expression of ACE2 in the diabetic kidney has been well studied, little is known about its expression in non-diabetic renal disease. In the present study, we assessed ACE2 in rats with acute kidney injury induced by STNx (subtotal nephrectomy). STNx and Control rats received vehicle or ramipril (1\u00a0mg\u00b7kg\u22121 of body weight\u00b7day\u22121), and renal ACE, ACE2 and mas receptor gene and protein expression were measured 10\u00a0days later. STNx rats were characterized by polyuria, proteinuria, hypertension and elevated plasma ACE2 activity (all P&amp;lt;0.01) and plasma Ang-(1\u20137) (P&amp;lt;0.05) compared with Control rats. There was increased cortical ACE binding and medullary mas receptor expression (P&amp;lt;0.05), but reduced cortical and medullary ACE2 activity in the remnant kidney (P&amp;lt;0.05 and P&amp;lt;0.001 respectively) compared with Control rats. In STNx rats, ramipril reduced blood pressure (P&amp;lt;0.01), polyuria (P&amp;lt;0.05) and plasma ACE2 (P&amp;lt;0.01), increased plasma Ang-(1\u20137) (P&amp;lt;0.001), and inhibited renal ACE (P&amp;lt;0.001). Ramipril increased both cortical and medullary ACE2 activity (P&amp;lt;0.01), but reduced medullary mas receptor expression (P&amp;lt;0.05). In conclusion, our results show that ACE2 activity is reduced in kidney injury and that ACE inhibition produced beneficial effects in association with increased renal ACE2 activity. As ACE2 both degrades AngII and generates the vasodilator Ang-(1\u20137), a decrease in renal ACE2 activity, as observed in the present study, has the potential to contribute to the progression of kidney disease.<\/jats:p>","DOI":"10.1042\/cs20090318","type":"journal-article","created":{"date-parts":[[2009,8,21]],"date-time":"2009-08-21T15:00:02Z","timestamp":1250866802000},"page":"269-279","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition"],"prefix":"10.1042","volume":"118","author":[{"given":"Elena","family":"Velkoska","sequence":"first","affiliation":[{"name":"Department of Medicine, The University of Melbourne, Austin Health, Heidelberg 3081, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael\u00a0G.","family":"Dean","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne, Austin Health, Heidelberg 3081, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Burchill","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne, Austin Health, Heidelberg 3081, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki","family":"Levidiotis","sequence":"additional","affiliation":[{"name":"Western Hospital, Footscray 3011, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise\u00a0M.","family":"Burrell","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne, Austin Health, Heidelberg 3081, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2009,11,16]]},"reference":[{"key":"2021113010165090800_B1","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1001\/jama.283.24.3177","article-title":"Optimizing treatment of hypertension in patients with diabetes","volume":"283","author":"Cooper","year":"2000","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"2021113010165090800_B2","first-page":"89","article-title":"The importance of the intrarenal renin-angiotensin system","volume":"2","author":"Velez","year":"2008","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"2021113010165090800_B3","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"2021113010165090800_B4","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021113010165090800_B5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tem.2004.03.001","article-title":"ACE2, a new regulator of the renin-angiotensin system","volume":"15","author":"Burrell","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"2021113010165090800_B6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/01.HYP.0000196268.08909.fb","article-title":"Angiotensin-converting enzyme 2 and angiotensin-(1\u20137): an evolving story in cardiovascular regulation","volume":"47","author":"Ferrario","year":"2006","journal-title":"Hypertension"},{"key":"2021113010165090800_B7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.HYP.0000090322.55782.30","article-title":"Molecular mechanisms of inhibition of vascular growth by angiotensin-(1\u20137)","volume":"42","author":"Tallant","year":"2003","journal-title":"Hypertension"},{"key":"2021113010165090800_B8","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010165090800_B9","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1681\/ASN.2006050423","article-title":"Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes","volume":"17","author":"Ye","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010165090800_B10","doi-asserted-by":"crossref","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","article-title":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type\u00a01 receptor blockade using telmisartan","volume":"296","author":"Soler","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113010165090800_B11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","article-title":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy","volume":"41","author":"Tikellis","year":"2003","journal-title":"Hypertension"},{"key":"2021113010165090800_B12","doi-asserted-by":"crossref","first-page":"F353","DOI":"10.1152\/ajprenal.00144.2004","article-title":"The role of angiotensin converting enzyme 2 in the generation of angiotensin 1\u20137 by rat proximal tubules","volume":"288","author":"Li","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113010165090800_B13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur. Heart J."},{"key":"2021113010165090800_B14","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/ki.2008.497","article-title":"Decreased glomerular and tubular expression of ACE2 in patients with type\u00a02 diabetes and kidney disease","volume":"74","author":"Reich","year":"2008","journal-title":"Kidney Int."},{"key":"2021113010165090800_B15","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.2174\/138161207781662876","article-title":"ACE2 and diabetic complications","volume":"13","author":"Dean","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"2021113010165090800_B16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MNH.0b013e3282f945c2","article-title":"New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2: a potential target for treatment of hypertension and diabetic nephropathy","volume":"17","author":"Batlle","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"2021113010165090800_B17","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2353\/ajpath.2006.051091","article-title":"Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis","volume":"168","author":"Oudit","year":"2006","journal-title":"Am. J. Pathol."},{"key":"2021113010165090800_B18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/sj.ki.5002373","article-title":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice","volume":"72","author":"Soler","year":"2007","journal-title":"Kidney Int."},{"key":"2021113010165090800_B19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","article-title":"Loss of angiotensin converting enzyme-2 (ACE2) accelerates diabetic kidney injury","volume":"171","author":"Wong","year":"2007","journal-title":"Am. J. Pathol."},{"key":"2021113010165090800_B20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1523-1755.2001.060002715.x","article-title":"Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomised rats","volume":"60","author":"Cao","year":"2001","journal-title":"Kidney Int."},{"key":"2021113010165090800_B21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/snep.2001.26794","article-title":"Role of angiotensin II in tubulointerstitial injury","volume":"21","author":"Cao","year":"2001","journal-title":"Semin. Nephrol."},{"key":"2021113010165090800_B22","first-page":"783","article-title":"Adaptation to nephron loss. 2008","volume-title":"The Kidney","author":"Taal","year":"2008"},{"key":"2021113010165090800_B23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1113\/expphysiol.2007.040386","article-title":"Acute kidney injury in the rat causes cardiac remodelling and increases ACE2 expression","volume":"93","author":"Burchill","year":"2008","journal-title":"Exp. Physiol."},{"key":"2021113010165090800_B23a","first-page":"1105","article-title":"Role for renal angiotensin converting enzyme 2 in the adaption to nephron loss following subtotal nephrectomy in the rat","volume":"53","author":"Velkoska","year":"2009","journal-title":"Hypertension"},{"key":"2021113010165090800_B24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","article-title":"Upregulation of hepatic angiotensinconverting enzyme 2 (ACE2) and angiotensin-(1\u20137) levels in experimental biliary fibrosis","volume":"47","author":"Herath","year":"2007","journal-title":"J. Hepatol."},{"key":"2021113010165090800_B25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00004872-200018060-00013","article-title":"Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs","volume":"18","author":"Farina","year":"2000","journal-title":"J. Hypertens."},{"key":"2021113010165090800_B26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1113\/expphysiol.2007.040352","article-title":"Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor","volume":"93","author":"Lew","year":"2008","journal-title":"Exp. Physiol."},{"key":"2021113010165090800_B27","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/jama.1980.03310040028020","article-title":"Proteinuria during long-term captopril therapy","volume":"244","author":"Case","year":"1980","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"2021113010165090800_B28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1440-1681.1984.tb00294.x","article-title":"Localization of angiotensin converting enzyme in rat forebrain and other tissues by invitro autoradiography using 125I-labelled MK351A","volume":"11","author":"Mendelsohn","year":"1984","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021113010165090800_B29","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ki.2009.61","article-title":"Genetic deletion of the angiotensin-(1\u20137) receptor Mas leads to glomerular hyperfiltration and microalbuminuria","volume":"75","author":"Pinheiro","year":"2009","journal-title":"Kidney Int."},{"key":"2021113010165090800_B30","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","article-title":"Effects of renin-angiotensin system blockade on renal angiotensin-(1\u20137) forming enzymes and receptors","volume":"68","author":"Ferrario","year":"2005","journal-title":"Kidney Int."},{"key":"2021113010165090800_B31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.HYP.32.3.496","article-title":"Converting enzyme determines plasma clearance of angiotensin-(1\u20137)","volume":"32","author":"Yamada","year":"1998","journal-title":"Hypertension"},{"key":"2021113010165090800_B32","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice","volume":"55","author":"Wysocki","year":"2006","journal-title":"Diabetes"},{"key":"2021113010165090800_B33","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/01.HYP.0000126192.27644.76","article-title":"Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoproptective combination?","volume":"43","author":"Ye","year":"2004","journal-title":"Hypertension"},{"key":"2021113010165090800_B34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/physrev.1996.76.2.425","article-title":"Paracrine regulation of the renal microcirculation","volume":"76","author":"Navar","year":"1996","journal-title":"Physiol. Rev."},{"key":"2021113010165090800_B35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.HYP.25.4.663","article-title":"The renal medulla and hypertension","volume":"25","author":"Cowley","year":"1995","journal-title":"Hypertension"},{"key":"2021113010165090800_B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1990.1","article-title":"Renal medullary circulation: hormonal control","volume":"37","author":"Chou","year":"1990","journal-title":"Kidney Int."},{"key":"2021113010165090800_B37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00424-003-1173-1","article-title":"Angiotensin-(1\u20137) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors","volume":"447","author":"Magaldi","year":"2003","journal-title":"Pflugers Arch."},{"key":"2021113010165090800_B38","first-page":"651","article-title":"Angiotensin-(1\u20137) is a potent antidiuretic peptide in rats","volume":"25","author":"Santos","year":"1992","journal-title":"Braz. J. Med. Biol. Res."},{"key":"2021113010165090800_B39","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.HYP.27.4.875","article-title":"Evidence for a physiological role of angiotensin-(1\u20137) in the control of hydroelectrolyte balance","volume":"27","author":"Santos","year":"1996","journal-title":"Hypertension"},{"key":"2021113010165090800_B40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0167-0115(98)00038-X","article-title":"Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1\u20137) antagonist in normotensive and hypertensive rats","volume":"74","author":"Simoes\u00a0e\u00a0Silva","year":"1998","journal-title":"Regul. Pept."},{"key":"2021113010165090800_B41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.regpep.2006.06.005","article-title":"Renal function in transgenic rats expressing an angiotensin(1\u20137)-producing fusion protein","volume":"137","author":"Ferreira","year":"2006","journal-title":"Regul. Pept."},{"key":"2021113010165090800_B42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem. J."},{"key":"2021113010165090800_B43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/path.1670","article-title":"Renal ACE2 expression in human kidney disease","volume":"204","author":"Lely","year":"2004","journal-title":"J. Pathol."},{"key":"2021113010165090800_B44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2007.11.022","article-title":"Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls","volume":"51","author":"Mizuiri","year":"2008","journal-title":"Am. J. Kidney. Dis."},{"key":"2021113010165090800_B45","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/diacare.29.04.06.dc05-1873","article-title":"Tissue gene expression of renin-angiotensin system in human type\u00a02 diabetic nephropathy","volume":"29","author":"Konoshita","year":"2006","journal-title":"Diabetes Care"},{"key":"2021113010165090800_B46","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.107.108944","article-title":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents","volume":"51","author":"Hernandez\u00a0Prada","year":"2008","journal-title":"Hypertension"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/118\/4\/269\/440663\/cs1180269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/118\/4\/269\/440663\/cs1180269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T10:33:19Z","timestamp":1638268399000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/118\/4\/269\/68827\/Reduction-in-renal-ACE2-expression-in-subtotal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,16]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,2,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20090318","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,16]]}}}